chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report, as received from a company representative, refers to a female patient of less than twenty years old (not further specified). Her medical history was unknown. On an unspecified date, the patient was allegedly vaccinated with M-M-R II. She then (about a month ago, in November 2013) developed mumps and symptoms of extremely swollen glands in the lymph node area under the ears. The patient sought medical attention because of the adverse events, by going to the health department. A buccal test and blood test for mumps were performed on an unknown date. The results of the tests were unknown. The outcome of mumps and symptoms of extremely swollen glands in the lymph node area under the ears was unknown. A causality assessment was not provided. This report is linked with report 1312USA006048, 1312USA006053 and 1312USA008378, received from the same reporter, regarding the additional patients, who also allegedly underwent vaccination with M-M-R II, and then developed mumps. It was stated that all patients in the linked reports were in close contact to one another by being related or working together. Additional information has been requested.
Headache, nausea, lightheaded, no syncope, no emesis. Self-limited but several hours after vaccine.
It started with itching all over even when when sleeping.  Then, developed hives and a rash on his hand. Then on day 6th, he had hives on the truck of his body and the itching was still continuing.  I went to his pediatrician and told me to give him Claritin for a month.  If he skips a dose of the medicine, the hives and itching will come back.
Bloody diarrhea.  Blood dripping from anus. Fever. Lethargic.  Sleeping constantly.  Body aches all over. Extreme abdominal pain.
started to lose the sense of smell and taste again; started to lose the sense of smell and taste again; This spontaneous case was reported by a health care professional and describes the occurrence of ANOSMIA (started to lose the sense of smell and taste again) and AGEUSIA (started to lose the sense of smell and taste again) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced ANOSMIA (started to lose the sense of smell and taste again) and AGEUSIA (started to lose the sense of smell and taste again). At the time of the report, ANOSMIA (started to lose the sense of smell and taste again) and AGEUSIA (started to lose the sense of smell and taste again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medication  included yes but was not given and treatment taken was not reported.
Heart Problems; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 68-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8733, Expiration date: Unknown), via an unspecified route of administration in the left arm on 15Apr2021 at 10:00 (at the age of 68-year-old) as first dose, single dose; second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8733, Expiration date: Unknown), via an unspecified route of administration in the left arm on an unknown date (at the age of 68-year-old) as single dose for COVID-19 immunisation in doctor's office/urgent care. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Medical history included thyroid from an unknown date and unknown if ongoing. Concomitant medication included AMOUR at 90 MG taken for an unspecified indication from unknown date and unknown if ongoing. The patient previously took penicillin b, sulfur; all from unknown dates to unknown dates for unknown indications. The patient experienced heart problems now (at the time of reporting) seeing cardiologists on 07May2021. Device date: 11Jun2021. The event resulted to physician's office visit. The events were assessed as serious (medically significant). The patient was received an unknown treatment for event. The patient underwent tab test and procedures included nuclear stress test, echocardiogram, heart cath (Cardiac catheterization) on an unknown date with unknown result. The outcome of the event was reported as reported as not resolved.  Follow up attempts are needed; information about lot/batch number has been requested as both lot/batch numbers are same and further information has been requested.
Initial misuse report received from a nurse on 02 December 2013.  A 4-year-old child patient had received 0.25 ml of FLUZONE. (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
Client c/o feeling lightheaded and  "feverish." Appeared diaphoretic and pallor. Client led to zero gravity chair.  V/S @ 10:25am BP 140/80, HR 59, O2 100. V/S @ 10:30 BP 118/76, HR 69, O2 99, RR 14. Client report 5/10 light-headed and "cooling down." Client offered and accepted water. V/S @ 10:40 BP 122/78, HR 66, O2 99, RR 12 and client statement "back to normal temp."  at 10:55am, client left observation area unassisted and with a steady gait.
There was no known adverse event that is known. Instructed to create a VAERS report to track the vaccine error.
Arm pain, then severe body pain and severe headache throughout the night of Friday 7, all day Saturday, Sunday I woke up well, only in small pain at the place of the vaccine. My wife had the same symptoms and also the feeling of disgust, the headache affected her the most, on Sunday the 8th the strongest reaction had passed.
I had localized granuloma annulare on my hands (top of hands). I have shingles vaccine - and within 2 weeks I had generalized granuloma annulare on both arms, upper chest, both legs, front and back of all arms and all legs.
This spontaneous report received from a patient through social media via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included: Covid-19. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported. Per procedure, no follow-up will be requested for this case. On an unspecified date, the patient experienced have Covid-19 again presently. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of have Covid-19 again presently was not reported. This report was non-serious. This report was associated with product quality complaint: 90000217338. The suspected product quality complaint has been confirmed to be voided (reported complaints were adverse events, hence was confirmed as voided. based on the PQC evaluation/investigation performed.
Rapidly losing my hair, and it is continuing to fall out. I only have 1/4 of my hair left.
I got sick after receiving my 2 Covid shots; This is a spontaneous report from a contactable consumer or other non hcp (patient reported for self). A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. On an unspecified date, the patient experienced I got sick after receiving my 2 covid shots. Patient got sick after receiving 2 Covid shots and now I want to know if I am immunized enough against the Covid. Am I protected against someone who is not vaccinated. Why should I take the booster shot. Outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  Follow-up attempts are completed. No further information is expected.
Chills, fever of 100.2 degrees F that started the evening of vaccination (vaccination was given around afternoon); still unresolved at time of reporting (afternoon the following day).
On 2/28/20 I woke up with balance problems made worse with eyes closed or when moving my head. These balance issues are slowly improving but remain ever present. I am also experiencing some cognitive issues including word finding problems, difficulty processing verbal information, and general brain fog. I?ve had an increase in fatigue as well. The same weekend the balance issues began I had some visual disturbances as well.
A 34 year old female patient received on 22 October 2007 a dose of Adacel (lot #C2824AA), intramuscular into the left deltoid.  She also received concomitantly Hep B vaccine (lot #AHBVB431BA), intramuscular into the right deltoid.  One day post vaccination, on 23 October 2007, the patient experienced erythema at the injection site, left deltoid and arthralgia of the left elbow.  She was seen in the office 2 days post vaccination.  Non steroidal inflammatory was prescribed.  Symptoms had eased and she had only small indurated area at the injection site of the left deltoid and joint pain in the left elbow.  Relevant diagnostic tests/laboratory data included: CBC, metabolic panel and Sedimenation rate (sed rate).  Results were not reported.  The patient medical history included allergy to sulfa.  The patient was not taking concomitant medications and had no illness at vaccination time.  No other vaccines given at the same time.  The patient did not have, per reporter, adverse event following prior vaccination.  The patient had not recovered.
shoulder and neck pain/left side pain to neck, shoulder, and upper back; shoulder and neck pain/left side pain to neck, shoulder, and upper back; shoulder and neck pain/left side pain to neck, shoulder, and upper back; Numbness in left arm; Fever of 99.5; swelling under left armpit and tonsils/swelling tonsil on left side; she had really bad body aches.; swelling under left armpit and tonsils; This is a spontaneous report received from a contactable pharmacist. A 51-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number was not reported) via an unspecified route of administration in Arm Left on an unspecified date (age at vaccination 51years old) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced shoulder and neck pain/left side pain to neck, shoulder, and upper back, numbness in left arm, fever of 99.5, swelling under left armpit and tonsils/swelling tonsil on left side, she had really bad body aches on an unspecified date. Clinical course was reported as She says after she got her first dose, she is still experiencing pain, and is due for her second dose in a week, which she doesn't know if she has to go or if she should wait until side effects clear. She declines to do a re-port and says that she has reported for a week every single day her symptoms, though it wasn't with Pfizer, it was the CDC. She says every day for 7 days they email questions about redness, chills, and muscle pain, which she didn't have that. She says two weeks she had fever of 99.5 (unable to clarify if this was degrees Fahrenheit during call) and the second day she had really bad body aches. She says she got her shot on her left side, which something cleared, then on day 8 she got swelling to her lymph or tonsil on the left side, then 2-3 days that was gone but she still has pain on the left side of her neck, shoulder, and upper back. She says she has been using a heating pad on her left side and taking Tylenol, though she doesn't have a temperature anymore she still has pain, it is better during the day and more intense at night. The patient underwent lab tests and procedures which included body temperature: 99.5 on unspecified date. The clinical outcome of the event numbness in left arm, she had really bad body aches, swelling under left armpit and tonsils was unknown and shoulder and neck pain/left side pain to neck, shoulder, and upper back event was not recovered and other events was recovered. Therapeutic measures were taken as a result of shoulder and neck pain/left side pain to neck, shoulder, and upper back, fever of 99.5.  No follow-up attempts are possible. Information about lot/batch cannot be obtained.
nausea, chills, lightheadedness/near-syncope, tremors, myalgias, fever, diarrhea
pt recvd MMR on 11FEB92 next day elevated sweats; no temp pt laying on floor staring-unresponsive for 30 mins; spinal tap & CAT scan done;
Patient is 12 years old and should have received the 12+ dose of the Pfizer vaccine but instead received the 5-11 dose
Fever (101)  around 16 hours after second dose, fatigue, headache, swollen lymph nose on left side,  pain at injection site
Extreme migraine took 2 Tylenol no relief after 4 hrs took another Tylenol no relief & was going to take another Tylenol & got nauseous & thru up, fever, migraine continued all day & was unable to sit up , was not hungry at all , could not sit up . Lasted all day only ate a few crackers that nt with a soda & went to bed , had a few min of rt ear ache but went away . Woke up next day 4/7/21 & felt pretty good . Since then have had a few slt instances of lightheaded ness dizzy feeling but only for a few seconds .
Pharmaceutical product complaint; 7 patients having received only the liquid diluent portion of Menveo; 7 patients having received only the liquid diluent portion of Menveo; 7 patients had received only the liquid diluent portion of Menveo; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 17-year-old patient who received Men ACWY-CRM NVS (Menveo) (batch number amva722z, expiry date 31st August 2022) for prophylaxis. This case was associated with a product complaint.   On 29th September 2022, the patient received Menveo. On 29th September 2022, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication, inappropriate dose of vaccine administered and expired vaccine used. On an unknown date, the patient experienced pharmaceutical product complaint. On an unknown date, the outcome of the inappropriate preparation of medication, inappropriate dose of vaccine administered, expired vaccine used and pharmaceutical product complaint were unknown.   Additional Information: GSK Receipt Date: 29-Sep-2022 Reporter's comment: The nurse reported that a possible 7 patients had received only the liquid diluent portion of Menveo.  The healthcare professional consents to safety team for follow up. These case was 7 out of 7 patient. The consent to follow up was granted. Additional Supportive Information: The nurse reported that a possible 7 patients had received only the liquid diluent portion of Menveo, which led to inappropriate preparation of medication, inappropriate dose of vaccine administered and expired vaccine used.; Sender's Comments:  US-GSK-US2022140223:Same reporter- Patient 3 US-GSK-US2022140233:Same reporter- Patient 6 US-GSK-US2022140231:Same reporter- Patient 5 US-GSK-US2022140222:Same reporter- Patient 2 US-GSK-US2022140225:Same reporter- Patient 4 US-GSK-US2022140220:Same reporter- Patient 1
606 doses were given after expiration date; Vaccine was stored after expiration date in the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator). On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Vaccine was refrigerated on 29-Oct-2021.  No treatment medications were reported.
I developed ''covid toes'' (blue toe syndrome) on all occasions of getting the vaccine. Right now, I still have scabs healing. It has been 10 weeks since my booster shot. I am healthy otherwise.; lost my sense of smell and taste somehow.; lost my sense of smell and taste somehow.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Jan2022 15:00 (Lot number: fl3197) at the age of 59 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Known allergies: wood dust" (unspecified if ongoing), notes: Known allergies: Cipro, wood dust, seasonal pollen; "Known allergies: seasonal pollen" (unspecified if ongoing), notes: Known allergies: Cipro, wood dust, seasonal pollen. The patient's concomitant medications were not reported. Past drug history included: Cipro for Known allergies: Cipro, notes: Known allergies: Cipro, wood dust, seasonal pollen. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: ew0187, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 22May2021, when the patient was 59 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0171, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 01May2021, when the patient was 59 years old, for COVID-19 immunization. The following information was reported: BLUE TOE SYNDROME (non-serious) with onset 04Jan2022, outcome "not recovered", described as "I developed ''covid toes'' (blue toe syndrome) on all occasions of getting the vaccine. Right now, I still have scabs healing. It has been 10 weeks since my booster shot. I am healthy otherwise."; ANOSMIA (non-serious), AGEUSIA (non-serious) all with onset 04Jan2022, outcome "not recovered" and all described as "lost my sense of smell and taste somehow.". Therapeutic measures were not taken as a result of blue toe syndrome, anosmia, ageusia.  Additional information: No other vaccine in four weeks. No other medications in two weeks. Patient had never been tested for Covid19. No COVID prior vaccination. No COVID tested post vaccination. 'Thin veins' run in the family.  No follow-up attempts are possible. No further information is expected.
Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On unspecified dates, since 19-AUG-2016, the patients received improperly stored doses of PROQUAD (lot # M006105 with expiration date 01-AUG-2017, therapy type rHA; lot # M010478 with expiration date 01-SEP-2017, therapy type HSA; lot # M012987, expiration date 12-SEP-2017, therapy type HSA; lot# M015695 with expiration date 26-SEP-2017, therapy type rHA; lot # M021427 with expiration date 29-OCT-2017, therapy type rHA; dose and route were not reported). It was reported that the vaccine was improperly stored at -3.5 Celsius for 1 hour and 6 minutes. There was no previous temperature excursion. Data logger was involved. No symptoms were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Dizziness, passed out, nausea, severe headache,  Body aches, fever of 101.6 on the second day On the third day fever of 101.1 off and on during the day, body aches, headache and extreme fatigue  Fourth day-extreme sore throat, extreme muscus, headache and continued fatigue  Fifth day, headache and fatigue , on and off dizziness
Seasonal Flue vaccine administered 10-27-09 in School Board office - arm sore immediately, achiness in site of injection - deep muscle pain and in L shoulder blade. States swelling of Left hand last night - Sl. redness today near deltoid area - warm to touch. Seen by NP who recommended BENADRYL.
Patient had large blistering rash at injection site and hives covering arms shortly after getting shot. Also throat closed. Ended up in the ER.
This case was reported by a non-health professional via call center representative and described the occurrence of injection site pain in a 19-year-old female patient who received MENVEO (batch number M16077, expiry date March 2018). On 12th January 2017, the patient received MENVEO .5 ml. On 12th January 2017, less than a day after receiving MENVEO, the patient experienced injection site pain and numbness. On an unknown date, the outcome of the injection site pain and numbness were unknown. It was unknown if the reporter considered the injection site pain and numbness to be related to MENVEO. Additional details were provided as follows: The patient received a dose of MENVEO in her left deltoid and experienced sharp pain at site. No other information was reported.
This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 72-year-old female patient who received SHINGRIX (batch number B5EK2, expiry date unknown). On 30th April 2018, the patient received the 1st dose of SHINGRIX .5 ml. On 30th April 2018, less than a day after receiving SHINGRIX, the patient experienced appetite lost. On 1st May 2018, the patient experienced fever and general body pain. On an unknown date, the outcome of the fever and general body pain were recovering/resolving and the outcome of the appetite lost was recovered/resolved. The reporter considered the fever, appetite lost and general body pain to be related to SHINGRIX. Additional details were provided as follows: On 30th April 2018 at 12:00, the patient received SHINGRIX vaccine in left deltoid and had loss of appetite in evening. The fever was 100.3 degree F and presented the next day accompanied by body aches.
On 01/28/04, I received Anthrax shot #5 to right arm.  Within 6-8 hours while at home I noticed itching and swelling.  I returned to the clinic on 01/29/04 with no changes and then again on 01/30/04 with increased itching, swelling and redness.